Ashley Walker, PhD discusses her research on the vascular contributions to late-onset Alzheimer’s disease.
Historically, it was believed that amyloid-beta plaques were the initiating factor for Alzheimer’s disease; yet recent evidence suggests that changes to the cerebral blood flow precede the accumulation of amyloid-beta. Two of the major risk factors for late-onset Alzheimer’s disease are old age and cardiovascular diseases. Thus, aging of the cerebral vasculature has emerged as a likely candidate contributing to initiation and/or progression of late-onset Alzheimer’s disease. With advancing age, there is increased stiffness of the large elastic arteries that is associated with cerebrovascular dysfunction and cognitive decline.
This webinar discusses the evidence for the vascular contributions to Alzheimer’s disease with a specific focus on large artery stiffness. Additionally, the importance of examining sex differences in vascular function and Alzheimer’s disease risk are also considered.
Key Topics Include:
- Develop an appreciation for the vascular contributions to late-onset Alzheimer’s disease
- Understand the functions of cerebral vascular endothelial cells
- Understand the evidence supporting the role of increased large artery stiffness in cerebrovascular dysfunction, neuropathology, and cognitive impairment
1. Copyright 2022. All Rights Reserved. Contact Presenter for Permission
Vascular Contributions to
Dementia
Ashley Walker, PhD
Assistant Professor
Human Physiology
University of Oregon
3. Vascular Contributions to Dementia:
Role of Arterial Stiffness
Ashley Walker, PhD
Assistant Professor
University of Oregon
aewalker@uoregon.edu
Vascularlab.uoregon.edu
@Ashley_E_Walker
6. For individuals diagnosed with Alzheimer’s disease,
how many have AD pathology in their brain?
B. 65%
A. 45% C. 85%
7. C. 85%
Data from: Kapasi, Acta Neuropathol, 2017, DOI: 10.1007/s00401-017-1717-7
For individuals diagnosed with Alzheimer’s disease,
how many have AD pathology in their brain?
8. For individuals diagnosed with Alzheimer’s disease,
how many have other pathology in their brain?
B. 66%
A. 36% C. 96%
9. For individuals diagnosed with Alzheimer’s disease,
how many have other pathology in their brain?
C. 96%
Data from: Kapasi, Acta Neuropathol, 2017, DOI: 10.1007/s00401-017-1717-7
10. In the brain of patients diagnosed with
Alzheimer’s disease:
*Other pathology: Lewy body,
TDP-43, hippocampal sclerosis
AD pathology
AD + Vascular pathology
Other pathology
No pathology
AD pathology (only)
AD and Other pathology
Other pathology (no AD)
No pathology
Data from: Kapasi, Acta Neuropathol, 2017, DOI: 10.1007/s00401-017-1717-7
13. AD pathology
AD + Vascular pathology
Other + Vascular
pathology
Other pathology
No pathology
*Other pathology: Lewy body,
TDP-43, hippocampal sclerosis
AD pathology(only)
Vascular pathology AND
AD pathology
No pathology
Vascular pathology (only)
Other pathology
In the brain of patients diagnosed with
Alzheimer’s disease:
Data from: Kapasi, Acta Neuropathol, 2017, DOI: 10.1007/s00401-017-1717-7
14. Iturria-Medina, 2016. Nature Communications, DOI: 10.1038/ncomms11934
Vascular dysregulation is the earliest
biomarker for late-onset Alzheimer’s disease
Healthy
control
Early mild
cognitive
impairment
Late mild
cognitive
impairment
Late-onset
Alzheimer's
disease
Biomarker
abnormality
15. Iturria-Medina, 2016. Nature Communications, DOI: 10.1038/ncomms11934
Vascular dysregulation is the earliest
biomarker for late-onset Alzheimer’s disease
Healthy
Control
Early mild
cognitive
impairment
Biomarker
abnormality
29. With age (and greater large artery stiffness),
the following occurs:
A. Systolic and diastolic blood pressure increase
B. Systolic blood pressure increases, diastolic blood
pressure decreases
C. Systolic blood pressure decreases, diastolic blood
pressure increases
D. Systolic and diastolic blood pressure decrease
30. With age (and greater large artery stiffness),
the following occurs:
A. Systolic and diastolic blood pressure increase
B. Systolic blood pressure increases, diastolic blood
pressure decreases
C. Systolic blood pressure decreases, diastolic blood
pressure increases
D. Systolic and diastolic blood pressure decrease
31. Pulse pressure increases with age
Pulse pressure (PP)
Mitchell, J Appl Physiol, 2008, DOI: 10.1152/japplphysiol.90549.2008
36. Small arteries have fewer elastic lamina and
respond poorly to greater pulsatility
100 um
10 um
Aorta
Cerebral artery
Arteries Capillaries Veins
Capillary
38. Low and high pulse pressure ex vivo in cerebral arteries
Nick Winder, MS
Posterior cerebral
artery (PCA)
Images created with Biorender.com
39. Pulse Conditions:
Low Pulse: 75 mmHg/50 mmHg
High Pulse: 87.5 mmHg/37.5 mmHg
400 bpm
Posterior cerebral
artery (PCA)
Images created with Biorender.com
Low and high pulse pressure ex vivo in cerebral arteries
46. Low pulse pressure ex vivo does not affect
endothelial function in cerebral arteries
Acetylcholine [log M]
PRE -9 -8 -7 -6 -5 -4
PCA
Vasodilation
(%)
0
20
40
60
Static Pressure
Low Pulse Pressure
Winder and Walker, In Review
47. High pulse pressure ex vivo impairs endothelial
function in cerebral arteries
Acetylcholine [log M]
PRE -9 -8 -7 -6 -5 -4
PCA
Vasodilation
(%)
0
20
40
60
Static Pressure
Low Pulse Pressure
High Pulse Pressure
*
Winder and Walker, In Review
48. Acetylcholine [log M]
PRE -9 -8 -7 -6 -5 -4
PCA
Vasodilation
(%)
0
20
40
60
Static Pressure
Low Pulse Pressure
High Pulse Pressure
*
Winder and Walker, In Review Raignault, JCBFM, 2016 https://doi.org/10.1177/0271678X16629155
High pulse pressure ex vivo impairs endothelial
function in cerebral arteries
49. High pulse pressure ex vivo impairs endothelial
function in cerebral arteries from young, but not old,
mice
Acetylcholine [log M]
PRE -9 -8 -7 -6 -5 -4
PCA
Vasodilation
(%)
0
20
40
60
Young
Young Low Pulse
Young High Pulse
Acetylcholine [log M]
PRE -9 -8 -7 -6 -5 -4
PCA
Vasodilation
(%)
0
20
40
60
Old
Old Low Pulse
Old High Pulse
*
Winder and Walker, In Review
50. Old cerebral arteries distend less and are
more stiff during high pulse pressure
Young High Pulse Old High Pulse
Winder and Walker, In Review
53. Eln+/+ Eln+/-
Aorta
Middle
Cerebral
Artery
Elastin heterozygote (Eln+/-) mice as a model of
large artery stiffness
100 um
100 um
10 um 10 um
• Eln+/- mice have lower elastin content in the large arteries, but not small
arteries.
0.0
0.5
1.0
Aortic
Elastin
Content
(AU)
Eln+/+ Eln+/-
0.0
0.5
1.0
MCA
Elastin
Content
(AU)
Eln+/+ Eln+/-
*
Green: elastin, Blue: nuclei
Walker, 2015, J Physiol, DOI: 10.1113/jphysiol.2014.285338
55. 0
200
400
Aortic
Pulse
Wave
Velocity
(cm/s)
Eln+/+ Eln+/-
*
Walker, 2015, J Physiol, DOI: 10.1113/jphysiol.2014.285338
Elastin heterozygote (Eln+/-) mice as a model of
large artery stiffness
• Eln+/- mice are a model of isolated stiffening of the large arteries.
0
5
10
15
MCA
Beta
Stiffness
Parameter
Eln+/+ Eln+/-
76. 3xTg-AD leads to decreased perfusion of the
entorhinal cortex, large artery stiffness does not
have an effect
Perfusion
(ml/100
g
tissue/min)
0
50
100
Eln+/+ Eln+/+
3xTgAD
Eln+/- Eln+/-
3xTgAD
*
N=5-12/group, *p<0.05 vs. Eln+/+
Eln+/+
Eln+/-
Eln+/+ x 3xTg-AD
Eln+/- x 3xTg-AD
Entorhinal cortex
Winder and Walker, unpublished
77. Perfusion
(ml/100
g
tissue/min)
0
50
100
150
Eln+/+ Eln+/+
3xTgAD
Eln+/- Eln+/-
3xTgAD
* *
*
Impaired vascular reactivity in the hippocampus
with the combination of greater large artery stiffness
and 3xTg-AD
N=5-12/group, *p<0.05 vs. 100% O2
100% O2
95% O2 / 5% CO2
Eln+/+ Eln+/-
Eln+/+ x 3xTg-AD Eln+/- x 3xTg-AD
100% O2
95% O2,
5% CO2
Hippocampus
Winder and Walker, unpublished
79. Large artery stiffness leads to more activated
microglia in the cerebral cortex
Iba1
positive
area
(%)
0.00
0.25
0.50
0.75
Eln+/+ Eln+/+
3xTgAD
Eln+/- Eln+/-
3xTgAD
*
N=4-10/group, *p<0.05 vs. Eln+/+
Eln+/+ Eln+/-
Eln+/+ x 3xTg-AD Eln+/- x 3xTg-AD
Sahana Krishna Kumaran
Krishna Kumaran and Walker, unpublished
85. Acknowledgements
Aging and Vascular Physiology Lab:
Abigail Cullen, PhD
Emily Reeve, MS
Mackenzie Kehmeier, MS
Nick Winder, MS
Grant Henson, MS
Jessica LaFarga, MS
Funding:
National Institutes of Health: National Institute on Aging
Alzheimer’s Association
John L Luvaas Family Fund
Oregon Medical Research Foundation
Oregon Charitable Checkoff Donations for Alzheimer's research
Images created with BioRender
Elise Kronquist
Kerrick Chinen
Jazmin Cole
Sahana Krishna Kumaran
Julia Wolf
Byron Lee
Hanson Pham
Bradley Bedell
Aleena Khurana
Nayantara Arora
Max Braker
Audrey Cannon
Holly D’Amico
Collaborators:
Marty Pike, PhD, OHSU
Nabil Alkayed, MD, PhD, OHSU
Randy Woltjer, MD, PhD, OHSU
Laura Villasanna, PhD, OHSU
Dean Li, MD, PhD, U of Utah
Tony Dontao, PhD, U of Utah
Lisa Lesniewski, PhD, U of Utah
86. Thank you for participating!
CLICK HERE to learn more and
watch the webinar